| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Credit > Commercial Collections And Credit Granting |
|
Subjects - Commercial Collections And Credit Granting
It is estimated that billions of dollars in delinquent commercial credit is currently being carried on the books of both American and international businesses. This figure changes as our economy grows or contracts. Increased competition, diversification of According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product product lines seem to indicate that these figures will continue to move upward. Regardless of the state of either the national or international economy, the necessity to grant credit and to collect commercial receivables using professional methods remains v ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ital to all businesses. Credit Sales Volumes Are Important The average commercial business sell between two to five percent of their products for cash. The credit department is responsible for the other 95 to 98 percent of the goods and/or services sold. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. usinesses have varying percentages of their financial resources tied up in receivables. Actual losses might range from one-half of one percent to five percent of sales without serious results. This depends on profit margin and other factors. Losses can expl here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ode to significant sums very fast if not restricted by the credit manager. Good Customer Relations Are Paramount The credit department must also be in tune with customer relations. This quality is absolutely necessary in order for the company to prosper w d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hen selling on credit. It is very, very easy to say "no" to prospective customers, and it is also very easy to firmly demand payment at the time of the sale. If this attitude reduces sales, then the credit department is not performing its complete function, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc which is to create a balance between sales and collection of money. When extending credit to a new customer, the following basic information should be harvested for your credit evaluation and kept on file: Is the firm individually owned, a partnership or easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a corporation?
You must obtain full names of owners, partners or officers and all business addresses. This is a must. A follow-up form letter to the hastily approved customer may supply this information and the local city directory may be helpful with deta nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ils of ownership or tenancy. You should, however, get the information before delivery of the merchandise. How long has the applicant been in business? Statistics show that 50 percent of business failures are firms less than one year old, 75 percent are le and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s than five years old. At what bank does the applicant do business? What is the average size of his bank balance and are there any loans outstanding? The customer may have a financial statement which will reveal this, and certainly a phone call to their b ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ank manager is in order. They might only confirm the existence of an account, unless your customer pre-approves release of the details. A carefully worded and signed application will gain you the most information. What do the records show? Are financing a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a greements kept, or have legal suits been filed? If the amount of credit requested is substantial, additional financial information may be secured from an outside credit information source such as another supplier trade association or business reference. n W dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod at are some of the business firms with which the applicant is currently dealing? You will want to check with at least three companies to determine how much credit has been extended and the creditors’ payment experience with the applicant company. This proce cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin dure may help you and other businesses in exposing customers who exploit their suppliers. Search for Patterns of Problems It is a constructive idea to analyze those customers who have become collection problems and to note reasons for their delinquency. A tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pattern will probably be revealed. It may be found that some collection problems involve businesses which were in operation less than a year at the time credit was originally granted. This is a "red flag." It does not mean that a new business should be de t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ied credit, but it does mean that additional information should be obtained to ensure that the business is potentially a good credit risk. Sometimes the credit manager will have to deal with a sales person who is overanxious or under-trained. In the desire ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust to sell, they may make promises that lead to collection problems. When such a pattern develops in an area, it would then be wise to advise the sales manager about the problem. It is often expedient with large orders to send the potential customer a letter y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products spelling out credit terms. Some Delinquencies Are Unavoidable It is inevitable in granting credit that certain conditions cannot be foreseen and that there will be unavoidable delinquencies. It is usually acceptable company policy that credit losses with . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de n certain percentage limits can be sustained, as growth can only be achieved by reasonable risk taking. Reserves for bad debts and collection costs are an acceptable and recognized expense for business. A too-tight credit policy can dry up potential growth. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip A too-loose credit policy can be a great expense. By granting credit intelligently and by following good billing and collection procedures, it is possible to hold risk to an acceptable figure—to a balance between company growth and losses due to bad debts tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Need Temporary Office Space... But Don't Have A Big Budget? 10 Strategic Ways To Maximize Your Profits Using Your Name to Generate Traffic
|